Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

pritelivir

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
  • K. Shiraki
  • Advances in experimental medicine and biology
  • 2018
  • Corpus ID: 48365052
The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes… Expand
2016
2016
Importance Current therapy of herpes infections relies on nucleoside analogues. Pritelivir is a well-tolerated novel herpes… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2016
2016
A mathematical model for antiviral clinical trials improves dose selection and understanding of drug-virus interaction. Dosing… Expand
Review
2016
Review
2016
Herpes simplex virus (HSV) types 1 and 2 can cause infections with clinical manifestations ranging from benign and generally self… Expand
  • figure 1
2016
2016
Background. Pritelivir is a novel helicase-primase inhibitor in clinical development for treatment of herpes simplex virus type 2… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Review
2015
Review
2015
The seminal discovery of acyclovir 40 years ago heralded the modern era of truly selective antiviral therapies and this drug… Expand
Highly Cited
2014
Highly Cited
2014
BACKGROUND Pritelivir, an inhibitor of the viral helicase-primase complex, exhibits antiviral activity in vitro and in animal… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
2014
2014
1. Balcells ME, Thomas SL, Godfrey-Faussett P, Grant AD. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg… Expand
  • figure 1
Review
2013
Review
2013
This review starts with a brief description of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), the clinical diseases they… Expand
2013
2013
Fifty-nine US isolates of HSV-1 and HSV-2 obtained between 1998 and 2004 were tested for sensitivity to the helicase-primase… Expand